These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1714114)

  • 1. The molecular basis of familial chylomicronemia.
    Ameis D; Schotz C; Greten H
    Z Gastroenterol Verh; 1991 Mar; 26():102-3. PubMed ID: 1714114
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial chylomicronemia syndrome.
    Mohandas MK; Jemila J; Ajith Krishnan AS; George TT
    Indian J Pediatr; 2005 Feb; 72(2):181. PubMed ID: 15758547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry.
    Foubert L; Bruin T; De Gennes JL; Ehrenborg E; Furioli J; Kastelein J; Benlian P; Hayden M
    Hum Mutat; 1997; 10(3):179-85. PubMed ID: 9298816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial chylomicronemia syndrome.
    Sugandhan S; Khandpur S; Sharma VK
    Pediatr Dermatol; 2007; 24(3):323-5. PubMed ID: 17542893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.
    Ishimura-Oka K; Faustinella F; Kihara S; Smith LC; Oka K; Chan L
    Am J Hum Genet; 1992 Jun; 50(6):1275-80. PubMed ID: 1598907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial lipoprotein lipase deficiency].
    Yoshida T; Gotoda T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):84-7. PubMed ID: 9645014
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia.
    Wiebusch H; Funke H; Santer R; Richter W; Assmann G
    Hum Mutat; 1996; 8(4):392. PubMed ID: 8956052
    [No Abstract]   [Full Text] [Related]  

  • 8. Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
    Wiebusch H; Funke H; Bruin T; Bucher H; von Eckardstein A; Kastelein JJ; Assmann G
    Hum Mutat; 1996; 8(4):381-3. PubMed ID: 8956048
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
    Reina M; Brunzell JD; Deeb SS
    J Lipid Res; 1992 Dec; 33(12):1823-32. PubMed ID: 1479292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chylomicronemia].
    Yamamoto T; Kawakami M
    Nihon Rinsho; 1990 Nov; 48(11):2526-31. PubMed ID: 2270016
    [No Abstract]   [Full Text] [Related]  

  • 11. Chylomicronemia syndrome.
    Rao AG; Konda C; Jhamnani KK
    Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293528
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).
    Haubenwallner S; Hörl G; Shachter NS; Presta E; Fried SK; Höfler G; Kostner GM; Breslow JL; Zechner R
    Genomics; 1993 Nov; 18(2):392-6. PubMed ID: 8288243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
    Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA
    Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial chylomicronemia in a nine months old infant.
    Lone SW; Imdad A; Billoo AG
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):655-6. PubMed ID: 18940129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial commentary: Dietary management of familial chylomicronemia syndrome.
    Williams L; Wilson DP
    J Clin Lipidol; 2016; 10(3):462-5. PubMed ID: 27206931
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial chylomicronemia and multifactorial chylomicronemia.
    Muñiz-Grijalvo O; Diaz-Diaz JL
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():56-62. PubMed ID: 34006355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose cell size and distribution in familial lipoprotein lipase deficiency.
    Peeva E; Brun LD; Ven Murthy MR; Després JP; Normand T; Gagné C; Lupien PJ; Julien P
    Int J Obes Relat Metab Disord; 1992 Oct; 16(10):737-44. PubMed ID: 1330953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid restriction site screening method for the Pro207-->Leu mutation in the lipoprotein lipase gene.
    Lévesque G; Julien P; Deshaies Y; Lupien PJ; Ven Murthy MR
    Hum Mutat; 1994; 3(4):416-7. PubMed ID: 7915934
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
    Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.